Algoma Steel to Cut 1,000 Jobs Due to US Tariffs
Canadian steel giant Algoma Steel will slash 1,000 jobs and shut its blast furnace in Ontario, blaming US tariffs for heavy losses. The layoffs start March 23, 2025. Read more.
Category : Search result: pharmaceutical tariffs
NHS to pay 25% more for drugs in US trade deal
The UK's NHS will pay 25% more for innovative drugs in a new US trade deal, costing £3bn over three years. In return, UK pharma exports to the US avoid hefty tariffs. Read the full analysis.
US Grants UK 3-Year Tariff Exemption on Pharma Imports
The US extends a critical tariff exemption for UK pharmaceutical and medical technology imports for three years, supporting supply chains and public health. Read the full analysis.
Indian Businesses See US Tariffs as Strategic Cost
Despite new US tariffs, some Indian exporters in sectors like chemicals and engineering find them manageable. They cite strategic market access and competitive advantages as key reasons. Explore the nuanced impact on India-US trade.
Indian Pharma Pivots to Innovative Products: PHARMEXCIL
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Global Tenders for 65+ Patented Drugs in India
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Ramaswamy's net worth jumps 80% to $1.8 billion
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma China Facility Targets Break-Even by FY26
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister's Directive to Pharma Industry
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US Trade Deal: $500B Target & Stock Gains
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Smallcap Pharma Stock Gains 10% Despite Market Sell-Off
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharma Soars 10% Despite 47% Yearly Loss
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Pakistan Factory Boiler Blast Kills 15 in Punjab
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Summit 2025: Pharma Partnerships for India's Growth
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma IPO: ₹895 Cr Offer Opens, ₹130 Grey Market Premium
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma IPO: ₹895 Crore Offer Opens Today
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
India Sends 3.5 Tonnes Medical Aid to Seychelles
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.
Sudeep Pharma IPO: 22% GMP, Opens Nov 21
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma IPO: ₹895 Cr Issue Opens Nov 21
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
India's October exports fall to $34.38B, deficit widens
India's merchandise exports declined to $34.38 billion in October as US tariff hikes take effect. Trade deficit widened to $41.68 billion. Read analysis of economic impact.
Evexia Lifecare Share Price Rises 3% on High Volumes
Evexia Lifecare share price gained over 3% with heavy trading volumes. Discover the Q2 FY26 results showing a sharp profit fall and the stock's long-term decline. Read analysis before investing.
Novo Nordisk brings back former CEO as chairman
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Hvax Technologies H1 FY26 Income Jumps 35%
Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.
Punjab Health Minister's Stern Warning to Drug Manufacturers
Punjab Health Minister Dr Balbir Singh issues strict quality warning to drug manufacturers after MP cough syrup incident. State adopts zero-tolerance policy on sub-standard medicines.
India Urges Russia to Fast-Track Export Approvals
India requests Russia to expedite approvals for Indian exporters in marine, pharmaceutical sectors during Moscow talks. Bilateral trade targets $100B by 2030. Key discussions ahead of Putin's December visit.
FSSAI bans misleading ORS ads, FDC's Electral validated
FSSAI cracks down on false ORS marketing claims. FDC Ltd welcomes action, reaffirming Electral's 50-year scientific legacy as genuine electrolyte solution.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
US-Switzerland Close to Resolving Trump Tariff Dispute
The United States and Switzerland are finalizing a deal to resolve steel and aluminum tariffs imposed during Trump's presidency. This agreement promises to ease trade tensions and boost bilateral relations between the two nations.
Page 1 of 4